Boothbay Fund Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,733
Closed -$476K 2265
2025
Q4
$476K Sell
2,733
-10,084
-79% -$1.84M 0.01% 1171
2025
Q3
$1.85M Sell
12,817
-39,934
-76% -$4.89M 0.03% 602
2025
Q2
$5.31M Buy
52,751
+28,336
+116% +$2.17M 0.1% 282
2025
Q1
$1.86M Sell
24,415
-9,390
-28% -$718K 0.05% 441
2024
Q4
$2.33M Sell
33,805
-9,912
-23% -$714K 0.06% 408
2024
Q3
$3.19M Buy
43,717
+30,301
+226% +$2.24M 0.07% 373
2024
Q2
$899K Sell
13,416
-31,363
-70% -$1.22M 0.02% 755
2024
Q1
$1.21M Buy
+44,779
New +$1.25M 0.02% 690
2023
Q4
Sell
-31,089
Closed -$785K 1807
2023
Q3
$785K Sell
31,089
-66,250
-68% -$1.52M 0.02% 864
2023
Q2
$2.05M Hold
97,339
0.05% 557
2023
Q1
$1.66M Buy
+97,339
New +$1.89M 0.03% 757
2022
Q3
Sell
-15,950
Closed -$382K 2408
2022
Q2
$315K Buy
+15,950
New +$334K 0.01% 1435
2021
Q4
Sell
-8,054
Closed -$222K 2026
2021
Q3
$222K Sell
8,054
-829
-9% -$21.7K 0.01% 1507
2021
Q2
$253K Buy
+8,883
New +$264K 0.01% 1383
2020
Q2
Sell
-19,418
Closed -$311K 1037
2020
Q1
$311K Buy
+19,418
New +$460K 0.03% 560
2018
Q1
Sell
-14,440
Closed -$380K 775
2017
Q4
$450K Buy
14,440
+5,249
+57% +$155K 0.07% 300
2017
Q3
$287K Buy
+9,191
New +$175K 0.05% 390

Other funds holding INSM

Boothbay Fund Management's INSM Position: Q1 2026 in Review

Boothbay Fund Management sold out of Insmed (INSM) in Q1 2026, closing a stake of 2,733 shares — an estimated $476K sold.

Boothbay Fund Management first reported a position in INSM in Q3 2017 and held it in 17 quarters. The position peaked at $5.31M in Q2 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Boothbay Fund Management reported no remaining Insmed position as of Q1 2026 after selling out during the quarter.
  • Boothbay Fund Management sold 2,733 Insmed shares in Q1 2026, an estimated $476K.
  • Boothbay Fund Management first reported a position in Insmed in Q3 2017 and held it in 17 quarters.
  • Boothbay Fund Management's Insmed position peaked at $5.31M in Q2 2025.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.